Patents by Inventor Peter Ydo Wielinga

Peter Ydo Wielinga has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10578611
    Abstract: The invention relates to the surprising find that low density lipoprotein receptor-deficient mice (LDLr?/?) mice when fed with high energy diets produce controllable and consistent diabetic complications, especially renal damage, similar to the human pathophysiology and biological response. The invention thus comprises a method for discovering a preventive or therapeutic regimen for the prevention or treatment of diabetic micro- or macrovascular complications, comprising the steps of: a. feeding LDLr?/? mice, which have not been treated with streptozotocin, with a high energy diet; b. before, during and/or after this diet treating the mice with the preventive or therapeutic regimen; c. checking whether any change in the micro- or macrovascular system of the animal occurs. Specifically in such a method renal damage is assessed. Also use of said mice fed with a high energy diet for studying the diabetic micro- and macrovascular complications is part of the invention.
    Type: Grant
    Filed: June 28, 2017
    Date of Patent: March 3, 2020
    Assignee: Nederlandse Organisatie Voor Toegepast-Natuurwetenschappelijk Onderzoek TNO
    Inventors: Robert Kleemann, Reinout Stoop, Johan Hendrikus Verheijen, Peter Ydo Wielinga, Teake Kooistra
  • Publication number: 20170363619
    Abstract: The invention relates to the surprising find that low density lipoprotein receptor-deficient mice (LDLr?/?) mice when fed with high energy diets produce controllable and consistent diabetic complications, especially renal damage, similar to the human pathophysiology and biological response. The invention thus comprises a method for discovering a preventive or therapeutic regimen for the prevention or treatment of diabetic micro- or macrovascular complications, comprising the steps of: a. feeding LDLr?/? mice, which have not been treated with streptozotocin, with a high energy diet; b. before, during and/or after this diet treating the mice with the preventive or therapeutic regimen; c. checking whether any change in the micro- or macrovascular system of the animal occurs. Specifically in such a method renal damage is assessed. Also use of said mice fed with a high energy diet for studying the diabetic micro- and macrovascular complications is part of the invention.
    Type: Application
    Filed: June 28, 2017
    Publication date: December 21, 2017
    Inventors: Robert KLEEMANN, Reinout STOOP, Johan Hendrikus VERHEIJEN, Peter Ydo WIELINGA, Teake KOOISTRA
  • Patent number: 9726664
    Abstract: The invention relates to the surprising find that low density lipoprotein receptor-deficient mice (LDLr?/?) mice when fed with high energy diets produce controllable and consistent diabetic complications, especially renal damage, similar to the human pathophysiology and biological response. The invention thus comprises a method for discovering a preventive or therapeutic regimen for the prevention or treatment of diabetic micro- or macrovascular complications, comprising the steps of: a. feeding LDLr?/? mice, which have not been treated with streptozotocin, with a high energy diet; b. before, during and/or after this diet treating the mice with the preventive or therapeutic regimen; c. checking whether any change in the micro- or macrovascular system of the animal occurs. Specifically in such a method renal damage is assessed. Also use of said mice fed with a high energy diet for studying the diabetic micro- and macrovascular complications is part of the invention.
    Type: Grant
    Filed: November 14, 2011
    Date of Patent: August 8, 2017
    Assignee: NEDERLANDSE ORGANISATIE VOOR TOEGEPAST—NATUURWETENSCHAPPELIJK ONDERZOEK TNO
    Inventors: Robert Kleemann, Reinout Stoop, Johan Hendrikus Verheijen, Peter Ydo Wielinga, Teake Kooistra
  • Publication number: 20130324423
    Abstract: The invention relates to the surprising find that low density lipoprotein receptor-deficient mice (LDLr?/?) mice when fed with high energy diets produce controllable and consistent diabetic complications, especially renal damage, similar to the human pathophysiology and biological response. The invention thus comprises a method for discovering a preventive or therapeutic regimen for the prevention or treatment of diabetic micro- or macrovascular complications, comprising the steps of: a. feeding LDLr?/? mice, which have not been treated with streptozotocin, with a high energy diet; b. before, during and/or after this diet treating the mice with the preventive or therapeutic regimen; c. checking whether any change in the micro- or macrovascular system of the animal occurs. Specifically in such a method renal damage is assessed. Also use of said mice fed with a high energy diet for studying the diabetic micro- and macrovascular complications is part of the invention.
    Type: Application
    Filed: November 14, 2011
    Publication date: December 5, 2013
    Inventors: Robert Kleemann, Reinout Stoop, Johan Hendrikus Verheijen, Peter Ydo Wielinga, Teake Kooistra